Über uns

À propos de nous

Nachhaltigkeit

Durabilité

Open Access

Karriere

Carrière

Datenschutz

Protection des données

Impressum

Mentions légales

Zahlung und Lieferung

Paiement et livraison

LEXIA

LEXIA Arbeitsrecht

Was ist LEXIA?

C'est quoi LEXIA ?

LEXIA Familienrecht

Zeitschriften

Revues

recht

Pflegerecht

ZBJV

forumpoenale

ZStrR

Anwaltsrevue

Revue de l'avocat

RSAS

FamPra.ch

ASYL

Life Science Recht

BlAR

Sachbuch

Livres spécialisés

LOKI

Semaphor

Fokusthemen

Focus

Thema

Recht studieren

Arbeitsrecht

Droit du travail

Studium

Études

Familienrecht

Droit de la famille

Sozialversicherungsrecht

Droit des assurances sociales

Strafrecht

Droit pénal

Publikationen

Publications

Literatur

Onlinemodule LEXIA

Modules en ligne LEXIA

Bücher

Livres

Buchreihen

Collections

Datenbanken

recht.ch

Studienliteratur

Littérature pour les études

Services

Dienstleistungen für

Corporate Books

Publishing Lösungen

Aktuelles

Geschäftskunden

Professionnels

Corporate Publishing

Content solutions

Buchhandlungen

Librairies

Veranstaltungen

Événements

Presse

Dozierende

Enseignants

Studierende

Étudiants

Inserierende

Annonceurs

Newsletter

Blog

Autorinnen/Autoren

Auteurs

Unsere Schreibenden

Hilfe

Unsere Autorinnen und Autoren

Liste

Autorenlounge

Espace des auteurs

Bei uns publizieren

Publier chez nous

Autorenstimmen

Témoignages

Verlag

Éditions

Themen

Mehr wissen

Mitarbeitende

Collaborateurs

Geschichte

Histoire

Vision und Mission

Vision et mission

Unser Magazin

Notre magazine

Unternehmenskultur

Culture d'entreprise

Partner

Partenaires

Kontakt

Contact

Shop

Schweizer Recht

Ausländisches Recht

Über unseren Shop

Neuerscheinungen

Nouveautés

Sortiment und Funktionen

Assortiment et recherche

Vorankündigungen

À paraître

Nach Rechtsgebiet

Par domaine juridique

Kommentare

Commentaires

de Gruyter Handbuch

&lt;p&gt;This book provides a comprehensive overview of European Patent Law. It presents a critical analysis of the European patent law system and the proposed changes to it. The book explores the strengths and weaknesses of the European Patent Convention, and the interaction between the national and the European level, as well as across borders. &lt;/p&gt;

Duncan Matthews

Paul Torremans

European Patent Law

The Unified Patent Court and the European Patent Convention

On June 1, the Unified Patent Court became operational and unitary patents are now available for filing.
This book provides an overview of the unitary patent system and offers additional strategic considerations, especially regarding the questions:
<ul>
<li>Should an "opt-out" be filed for existing European patents or not?</li>
<li>Should the Unified Patent Court be invoked?</li>
<li>How should proceedings before the Unified Patent Court be approached?</li>
<li>How do I defend myself if I am attacked?</li>
</ul>
It is a valuable aid for all those active in the field of patent protection in Europe, since, unlike a commentary, it provides comprehensive and concrete considerations from a strategic point of view and derives concrete proposals for action from them.
In addition, several chapters of the book are devoted to the enforcement of judgments of the Unified Patent Court as well as to the comparison between the Unified Patent Court and the patent jurisdiction of the member states. For this purpose, well-known guest authors could be won.
New:
<ul>
<li>Consideration of all relevant amendments to the law</li>
<li>Overview of national regulations in China, Korea, Japan and the USA</li>
<li>Appendix with relevant legal texts </li>
</ul>
Author:
Prof. Dr. Aloys Hüttermann is a patent attorney in Düsseldorf, co-editor of the planned commentary on the unitary patent system and known as a specialist in this field through numerous lectures.

Unitary Patent and Unified Patent Court

Munich Intellectual Property Law Center – MIPLC

The Relationship between Law and Biomedical Sciences in the Context of Article 53(a) of the European Patent Convention

Research Paper (postgraduate) from the year 2016 in the subject Law - Miscellaneous, grade: 1,0, University of Kaiserslautern, course: Patentrecht, language: English, abstract: This work investigates the behavior of patent trolling entities in the European, German and American patent system. Legislative, judicial, executive and private measures with the intent to contain the rent seeking and abusive conduct of patent trolling entities are discussed. Moreover, the impact of these measures on other entities in the patent system are examined. The most efficient measures are assumed to show a high selectivity and a strong impact on the business model of the trolling entity, while negative effects on other entities are minimal or non-existent and positive effects are preferred. According to these requirements, suitable measures to increase the patent quality like improving the patent examination processes of the patent office or the inter partes and the post-grand review are debated. Furthermore, the introduction of a peer to patent network or Patent Investment Trusts (PIT) are examined. To cut through growing patent thickets, the collaboration with patent pools or patent pledges is proposed. At last, the differences between the European, German and American patent system regarding their vulnerability to trolling entities are elucidated. In the end, containment measures against patent trolling behavior should selectively target the business model of patent trolling, which is expected to arise from the weak spots of the patent system.

Joscha P. Bartmann

Jonas M. Schulz

Trolling behavior in the European and American patent system. The impact of regulatory and private containment measures on practicing and non-practicing entities

SpringerBriefs in Law

Nikola Ilic

Theory, Economic Impact, and Future Trends

Law and Economics of Patents

Munich Studies on Innovation and Competition

&lt;p&gt;The patent system is based on "one-patent-per-product" presumption and therefore fails to sustain complex follow-on innovations that contain a number of patents. The book explains that follow-on innovations may be subject to market failures such as hold-ups and excessive royalties. For decades, scholars have debated whether the market problems can be solved with voluntary licensing i.e., open innovation, or with compulsory liability rules. The book concludes that neither approach is sufficient. On the one hand, incentives to engage in open innovation practices involving patents are insufficient. On the other hand, the existing compulsory liability rules in patent and competition law are not tailored to address follow-on innovator's interests. To transcend this problem, the author proposes a compulsory liability rule against the suppression of follow-on innovation, that paradoxically, fosters early-on voluntary licensing between patent holders and follow-on innovators. The book is aimed at patent and competition law scholars and practitioners, patent attorneys, managers, engineers and economists who either engage in open innovation involving patents or conduct research on the topic. It also offers insights to policy and law-makers reviewing the possibilities to foster open innovation initiatives or adapt the scope of patent remedies or employ compulsory licenses for patents.&lt;/p&gt;

Alina Wernick

Liability Rules vs. Open Innovation Models

Mechanisms to Enable Follow-On Innovation

EPCA practical guide and reference book for the EQE legal exams and EPAC

EPC Handbook

Seminar paper from the year 2010 in the subject Business economics - Business Management, Corporate Governance, grade: "noch nicht bekanntgegeben", Baden-Wuerttemberg Cooperative State University (DHBW), language: English, abstract: For many years now China represents one of the most popular target markets of the internationalisation of enterprises. The speed of economic development and social changes of China during the last years is indeed enormous and far above average. Today China is already the second largest economic nation and for many years receives the highest foreign investments worldwide. In 2002 China became Germany’s biggest Asian trading partner taking the leadership over from Japan.  Additionally 2012 shall be the German-Chinese cultural year.  A comparable rapid change and development can be seen in the field of biotechnology. Over the last few years biotechnology became more and more important, popular and underwent a tremendous boom.Pharmaceutical industry is a sunrise industry, especially the biopharmaceuticals, which just starts its large-scale industrialization process. Many large biotech and pharmaceutical companies are strengthening their presence worldwide and have already entered the Chinese market - Roche, Novartis, GlaxoSmithKline and Pfizer, to name but a few.  Among these as well BASF operates a joint venture together with the Chinese enterprise Sinopec for the production of high-quality chemical products and polymers. This seminar paper evaluates possible market entry strategies for the small and medium enterprise MediGene AG into China taking account of socio-cultural particularities. In the second chapter this seminar paper gives an insight into the characteristics of the Chinese culture and the biotechnological market in the People’s Republic of China.The subsequent third chapter contains information about the products and today’s internationalisation of MediGene. The fourth chapter is addressed to the different market entry strategies into China, which MediGene could choose. Finally, the seminar paper comes out with a conclusion and recommendation for MediGene considering the won findings.

Annike Stahl

The Biotechnology Company MediGene and the People's Republic of China

The Entrance in Foreign Markets  in the Field of Biotechnology and the Consideration of Socio-Cultural Particularities

European Patent Law

Autres titres sur ce thème